30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

ORTH ANDREW C.

Insider profile

ORTH ANDREW C.'s trades of Krystal Biotech Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-10-02 2023-10-02 PrS Proposed sale
41,239
491.85
US$3,333,669
41,239 491.85 US$3,333,669
2023-08-21 2023-08-21 PrS Proposed sale
99,369
128.89
US$1,734,332
99,369 128.89 US$1,734,332
2023-08-16 2023-08-16 PrS Proposed sale
58,264
309.81
US$2,051,047
58,264 309.81 US$2,051,047
2023-08-15 2023-08-15 PrS Proposed sale
8,048
122.01
US$981,922
8,048 122.01 US$981,922
2023-08-11 2023-08-11 PrS Proposed sale
1,503
122.02
US$183,392
1,503 122.02 US$183,392
2023-08-10 2023-08-10 PrS Proposed sale
5,606
122.22
US$685,185
5,606 122.22 US$685,185
2023-06-09 2023-06-09 PrS Proposed sale
12,500
128.00
US$1,600,000
12,500 128.00 US$1,600,000
2023-06-09 2023-06-09 PlS Planned sale
333 -76.9%
129.70
US$43,189
333 -76.9% 129.70 US$43,189
2023-06-09 2023-06-09 PlS Planned sale
6,906 -94.1%
128.94
US$890,488
6,906 -94.1% 128.94 US$890,488
2023-06-09 2023-06-09 PlS Planned sale
5,261 -41.8%
128.10
US$673,958
5,261 -41.8% 128.10 US$673,958